Charles S. Grob, M.D, endorses Healthcare Practitioner Access to Psilocybin for Professional Training
This page presents TheraPsil’s case for allowing healthcare professionals approved to conduct psychedelic treatment to have first-hand psilocybin experience as part of professional training. It includes a letter of support from Charles S. Grob, M.D. and background on TheraPsil’s training efforts.
Provider
Details
Enrollment
Course Overview
TheraPsil describes a need for more qualified healthcare professionals trained in psilocybin-assisted psychotherapy. The page explains that TheraPsil has been developing a training program that combines lectures, case studies, readings, discussions, and experiential learning. The featured material is a letter of support from Charles S. Grob, M.D., who argues that therapists who will guide psychedelic treatment may benefit from personal experience with psychedelics in order to better support patients and maintain safety. The content is intended for healthcare professionals, therapists, clinical counselors, nurses, social workers, and others involved in psilocybin-assisted psychotherapy or professional training related to psychedelic treatment.
Who is this for?
Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, social workers, and related practitioners.
Prerequisites
None stated on the page.
About the Provider
TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.
View TheraPsil profileCourse Details
- PricePrice on request
- Lifecycle statusDiscontinued
- SkillsIntegrationFacilitationPsychotherapyPsilocybin TherapyMDMA-Assisted Therapypsilocybin-assisted psychotherapy contextpatient safety awarenesstherapeutic support in altered states of consciousnesspost-experience integrationprofessional training in psychedelic carepsilocybin-assisted psychotherapypsychedelic therapy trainingclinical support for psychedelic treatmenttherapeutic safety and patient support
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jul 13, 2026
Accredited vs Non-Accredited Psychedelic Training
By AAA Learning Institute
Compare accredited and non-accredited psychedelic training programs, with an overview of what accreditation means and how to evaluate program quality. The page focuses on structure, practicum, curriculum, and practical considerations for prospective psilocybin facilitator students.
TheraPsil's Training Program
By TheraPsil
TheraPsil's professional training pathway prepares healthcare professionals and related practitioners for legal, ethical psychedelic-assisted care through didactic learning, live seminars, experiential components, and practicum-oriented training.
Course options
Fundamentals
Standard on-demand access
Full Programme
Standard on-demand access
Full Programme
Standard on-demand access
New Mexico Track
Standard on-demand access